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Background: ADRB-2 was implicated in rodent ovarian functions, including initial follicular growth. In contrast,
ADRB-2 expression and function in nonhuman primate and human ovary were not fully known but innervation and
significant levels of norepinephrine (NE), which is a ligand at the ADRB-2, were reported in the ovary.
Methods: We studied expression of ADRB-2 in human and rhesus monkey ovary (RT-PCR, immunohistochemistry; laser
micro dissection) and measured levels of norepinephrine (NE; ELISA) in monkey follicular fluid (FF). 3D cultures of
monkey follicles (4 animals) were exposed to NE or the ADRB-2 agonist isoproterenol (ISO), and follicular development
(size) was monitored. Upon termination expression of ADRB-2, FSH receptor and aromatase genes were examined.
Results: Immunohistochemistry and RT-PCR of either human follicular granulosa cells (GCs) obtained by laser
micro dissection or isolated monkey follicles revealed ADRB-2 in GCs of primordial, primary, secondary and tertiary
follicles. Staining of GCs in primordial and primary follicles was intense. In large preantral and antral follicles the
staining was heterogeneous, with positive and negative GCs present but GCs lining the antrum of large follicles
were generally strongly immunopositive. Theca, interstitial, and ovarian surface epithelial cells were also positive.
NE was detected in FF of preovulatory antral monkey follicles (0.37 + 0.05 ng/ml; n = 7; ELISA) but not in serum.
We examined preantral follicles ranging from 152 to 366 μm in diameter in a 3D culture in media supplemented
with follicle stimulating hormone (FSH). Under these conditions, neither NE, nor ISO, influenced growth rate in a
period lasting up to one month. Upon termination of the cultures, all surviving follicles expressed aromatase and
FSH receptors, but only about half of them also co-expressed ADRB-2. The ADRB-2 expression was not correlated
with the treatment but was positively correlated with the follicular size at the beginning and at the end of the
culture period. Hence, expression of ADRB-2 was found in the largest and fastest-in vitro growing follicles.
Conclusions: The results imply ADRB-2-mediated actions in the development of primate follicles. Drugs interfering
with ADRB-2 are used to treat medical conditions and may have unexplored effects in the human ovary.
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The catecholamines norepinephrine (NE) and dopamine
were found in high concentrations in human ovarian
homogenates and in follicular fluid (FF) of preovulatory
follicles. The source of these neurotransmitters is likely
the documented innervation of the human ovary by the
sympathetic nervous system or intra-ovarian neurons
[1-7]. NE is the main neurotransmitter of the sympa-
thetic nervous system and can affect receptor-bearing
cells. However, potential targets and roles of NE in the
human ovary are not well known.
Ovarian vascular cells and endocrine cells of the ovar-
ian follicle of several species, including humans, possess
different catecholaminergic receptors, including ADRB-2
[8-11]. Theca cells (TCs) and granulosa cells (GCs) ex-
press alpha- and beta-adrenergic receptors and their
activation regulates, for example, the levels of cAMP
and steroid production [7,12]. NE can also stimulate the
initial, FSH-independent growth of small follicles in the
neonatal rat in vitro [8]. Growth promoting actions initi-
ated by ADRB-2 were described in other organs, for
instance, in later stages of salivary gland growth [13] and
in the differentiation of stem cells [14]. Thus ADRB-2
may have physiological roles in stimulating growth/
differentiation of cells. This also appears to apply to
tumor cells, but to our knowledge it is not known,
whether ovarian tumors have been studied [15-18].
Recent data suggest that systemic exposure of rats to
the ADRB-2 agonist isoproterenol in vivo affected fol-
licular growth and androgen biosynthesis and induced a
polycystic ovarian phenotype. These changes were pre-
vented by propranolol, a blocker of ADRB [19]. Indeed
derangements of the actions of NE via ADRB-2 may be
related to the etiology of polycystic ovary syndrome
(PCOS) in women. This condition causes anovulatory
infertility and affects 5–10% of women of the reproduct-
ive age [20,21]. Evidence for hyper-innervation [22] of
the human PCOS ovary was reported. Increased sympa-
thetic activity associated with PCOS on one ovary, and
the effectiveness of stress-reducing exercise and even
acupuncture on the contralateral ovary within the same
patient, support the notion of a crucial role of sympathetic
innervation [22-26]. Experimental rat-PCOS models re-
veal an increased sympathetic tone and a dominant cate-
cholaminergic ovarian innervation [24]. Sectioning of the
superior ovarian nerve, which carries the majority of the
sympathetic fibers of the rat ovary, increased ovarian
ADRB-2 expression to normal levels, and restored estrous
cyclicity and the ability to ovulate [2,27]. These data imply
an important intra-ovarian role of NE, which is, at least in
part, mediated via ADRB-2.
Although the (sympathetic) innervation of the ovary
has been intensively studied [5,6], to date there are no
studies on the precise localization of ADRB-2 in thehuman ovary. Furthermore, the possibility that ADRB-2
may regulate follicular growth in human or nonhuman
primates has not been investigated. Yet, blockers of NE
receptors of the beta-type, so called beta-blockers, are
used for treating hypertension, angina, myocardial in-
farction, arrhythmias and heart failure. Some of them
target both adrenergic receptors ADRB-1 and 2 [28] and
hence knowledge about ovarian targets appears desir-
able. We addressed these issues using human and rhesus




The human and rhesus monkey ovarian samples used
for immunohistochemistry were identical to the ones
described in previous studies [29,30]. Additional sections
were cut from the blocks and used as described below.
Follicular culture
General care and housing of rhesus macaque monkeys
(Macaca mulatta) were provided by the Division of
Comparative Medicine at the Oregon National Primate
Research Center (ONPRC). The studies were conducted
in accordance with the NIH Guide for the care and Use
of Laboratory Animals and all protocols were approved
by the ONPRC Animal Care and Use Committee. Ani-
mals were pair caged in a temperature-controlled (22°C)
light-regulated 12L:12D room. Diet consisted of Purina
monkey chow (Ralston-Purina, Richmond, IN), provided
twice a day, supplemented with fresh fruit or vegetables
once a day and water ad libitum. Ovaries were collected
from 4 adult female rhesus macaques during necropsy
for other research or due to illness other than reproduct-
ive health issues. Ovaries from 3 additional animals were
used for pilot studies in order to establish the culture
conditions. The age of the animals ranged from 7–12
years. Blood samples were collected prior to the removal
of the ovaries, for steroid hormone measurements. Ovar-
ies were immediately transferred into HEPES-buffered
holding media (CooperSurgical, Inc., Trumbull, CT, USA)
supplemented with 0.2% (v/v) human serum protein sup-
plement (SPS, CooperSurgical, Inc.) and 10 μg/ml genta-
micin (Sigma-Aldrich, St Louis, MO, USA) at 37°C.
Ovarian tissue processing and 3D culture were de-
scribed previously [31-33]. In brief, secondary follicles
were dissected mechanically from cortical strips using
31-gauge needles. Only multilayered secondary follicles
(containing at least three layers of GCs) that displayed
the following characteristics were selected for encapsula-
tion in alginate hydrogel: 1) no clear antral cavity, 2) an
intact basement membrane with attached stroma, and 3)
a visible oocyte that was round and centrally located
within the follicle. Retrospective measurements showed
Table 1 Oligodeoxynucleotide primer pairs used in (RT-)
PCR experiments
Type Primer sequence (5′–3′) GenBank accession no.
Aromatase
Sense gcc ttt ttc tct tgg tgt gg NM_000103
Antisense atc ccc atc cac agg aat ct NM_000103
ADRB-2
Sense gag cac aaa gcc ctc aag ac NM_000024
Antisense tgg aag gca atc ctg aaa tc NM_000024
Nested-sense tag gca tca tca tgg gca NM_000024
FSHR
Sense ctg ctc ctg gtc tct ttg ct NM_000145.2
Antisense ggt ccc caa atc ctg aaa at NM_000145.2
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152 to 366 μm. Follicles were encapsulated in beads
composed of 0.25% sodium alginate (w/vol; 55%–65%
alginic acid; FMC BioPolymers (Philadelphia, PA) and
randomly transferred to individual wells of a 48-well
plate. For controls one group was cultured with media
containing 300 μl of alpha minimum essential medium
supplemented with 0.3% (v/v) human serum protein
supplement (CooperSurgical, Inc.), 1 mg/ml bovine
fetuin (Sigma-Aldrich, St. Louis, MO), 5 μg/ml insulin, 5
μg/ml transferrin, 5 ng/ml sodium selenite and FSH (3
ng/ml recombinant human (rh) FSH (NV Organon, Oss,
Netherlands). In a second group 100 nM norepinephrine
(NE; Sigma, St Louis, MO, USA) and in third group 100
nM of the non-selective ADRB-agonist isoproterenol
(ISO; Sigma) was added. Incubation was carried out at
37°C in a 5% oxygen environment (in 6% CO2/89% N2)
for approximately 30 days. Half of the culture media
(150 μl) was exchanged every other day.
Assessment of follicle survival and growth and RT-PCR
Follicle survival and diameters were assessed weekly [31]
using an Olympus (Tokyo, Japan) CK40 inverted micro-
scope attached to an Olympus PD11 digital camera
(Olympus Imaging America Inc., Center Valley, PA,
USA). Photographs of each follicle were collected and
imported to ImageJ 1.45 software. Follicles were mea-
sured from the outer layer of cells at the widest diameter
of the follicle and a second measurement perpendicular
to the first. The mean of these two values was then cal-
culated and named as the diameter of the follicle. Folli-
cles were classified as degenerating if the oocyte was no
longer surrounded by a layer of GCs, the oocyte was
dark, the GCs had become dark and fragmented, or the
diameter of the follicle decreased.
At the end of the culture period, all surviving follicles
were harvested and frozen until extraction of RNA
(Absolutely RNA Nanoprep Kit, Stratagene, Agilent
Technologies Inc., Santa Clara, CA, USA). For control
purposes, RNA was also extracted from freshly isolated
follicles that were not cultured. RNA (200–500 ng) was
subjected to reverse transcription, using random primers
(pdN6) and SuperScript II Reverse Transcriptase, 200 U/
μl (Invitrogen GmbH, Darmstadt, Germany). PCR steps
consisted of 35 cycles of denaturing (at 94°C for 60 sec),
annealing (at 60°C for 30 sec), and extension (at 72°C for
60 sec). Reaction tubes lacking the RT product input or
RNA input instead of cDNA were used as PCR controls.
The identities of all PCR products were verified by direct
sequencing, using one of the specific primers (Table 1).
Laser micro dissection (LMD) and RT-PCR
Human ovaries embedded in paraffin (Anatomie III, Cell
Biology; used in previous studies, e.g. [3,29,30]) were cutinto 5 μm sections and mounted onto a 1.35-μm poly-
ethylene naphthalene membrane pasted to a glass slide,
which had been pretreated with UV light for 30 min. The
sections were deparaffinized and processed for LMD as
previously described [34]. A nitrogen laser of the Robot-
MicroBeam (P.A.L.M. GmbH Mikrolaser Technologie,
Bernried, Germany), was used to circumscribe and then
isolate GCs of large follicles. Samples were ejected from
the object slide and catapulted directly into the cap of a
microfuge tube. 50 μl of RNA stabilization reagent
(RNEasy Protect Mini-Kit, Qiagen, Hilden, Germany)
were added into the cap. Samples were frozen at -70°C
until RNA extraction (RNEasy, Qiagen). RT followed by
two nested PCR amplifications was performed. The iden-
tities of all PCR products were verified by direct sequen-
cing, using one of the specific primers (Table 1).
Immunohistochemistry
Human (n = 4) and monkey (n = 6) ovarian sections were
subjected to immunohistochemistry as described [3,34].
Two different specific antisera to human ADBR-2 were
used: rabbit anti-ADBR2 at 1:50–1:100 dilution (Life
Span BioSciences Inc., Seattle, USA), and rabbit anti-
ADBR-2 at 1:400 dilution (IMGENEX Corporation, San
Diego USA). Secondary antisera (anti-rabbit biotinyl-
ated gamma globulin; 1:250; Vector Laboratories, Inc.
Burlingame, CA; USA), and avidin-biotin complex perox-
idase (ABC, Vector Laboratories) were used. The reactions
were visualized with diamino-benzidine (DAB; Sigma).
For control purposes, the primary antisera were replaced
by buffer, non-immune serum or rabbit IgG. Some sec-
tions were counterstained with hematoxylin in order to
visualize cell nuclei. Sections were observed with a Zeiss
Axiovert microscope (Zeiss, Jena, Germany).
Controlled ovarian stimulation (COS) protocol/NE ELISA
Follicular fluid (FF) was obtained from additional regu-
larly cycling female rhesus macaques undergoing COS
Merz et al. Journal of Ovarian Research  (2015) 8:8 Page 4 of 8protocols as previously described [35]. Samples for NE
ELISA stem from animals, which did not receive an ovu-
latory human chorionic gonadotropin stimulus (1000 IU
single injection i.m. (hCG, Novarel; Ferring Pharmaceu-
ticals) to initiate periovulatory events (n =7). Individual
preovulatory follicles (1–2 per ovary) were aspirated and
pooled using a 22-gauge needle during laparoscopy from
anaesthetized animals. The FF was centrifuged to
separate out GCs and blood cells. Blood samples were
obtained at the same time. Concentration of NE in FF
and serum was analyzed in duplicate at the Endocrine
Technology Core Lab (ONPRC) by a specific extraction-
ELISA kit (Norepinephrine (Research) ELISA, Cat# 17-
NORHU-E01-RES, ALPCO, Salem, NH). This kit assay
was validated for monkey serum and FF. The assay has
negligible cross-reactivity with at least 13 monoamines
including epinephrine and dopamine. The sensitivity of
the assay was 0.2 ng/ml, with a range of detection to 32
ng/ml. All FF samples were analyzed in one kit. The
intra-assay variation was estimated at 8.5%.Statistical analysis
Data were analyzed using Prism 5 (GraphPad Software,
San Diego, CA, USA). Results of ELISA measurements
data were analyzed by repeated-measures ANOVA
followed by the Newman-Keuls post-test. The data on
follicle diameter and growth were analyzed applying
nonparametric tests (see Results) since we have not
assumed Gaussian distribution (see Results). Data were
considered significant at P < 0.05 or less.Figure 1 ADRB-2 in monkey ovary. Expression by granulosa cells (GC), th
representative sections. Control (IgG instead of antiserum) (F). Bars: 30 μm.
immuno-positive and immuno-positive GC. Confirmation of ADRB-2 (100 b
(P: preantral follicles; SAF: small antral follicles; pools of 3 individual folliclesResults
ADRB-2 expression in human and monkey ovary
Immunohistochemistry identified ADRB-2 in GCs and
in TCs of human and monkey follicles (Figures 1 and 2).
Robust staining was observed in primordial and primary
follicles (in postnatal and adult ovary (Figures 1A and
2A). Staining of GCs in growing preantral and small
antral follicles was patchy and seen in most, but not all,
GCs (Figure 1B). In large antral follicles, staining of GCs
was in general heterogeneous, but the cells lining the
antrum were stained strongly (Figures 1C and 2B). Other
ovarian cells were immuno-positive, namely ovarian
interstitial gland and surface epithelial cells (Figure 1D,
E). Both antisera showed the same pattern (data not
shown). All controls performed were negative (see
Figures 1F and 2A). Expression of ADRB-2 by intact
monkey preantral and small antral follicle was confirmed
by RT-PCR followed by sequencing (Figure 1G). In
addition, a semi-nested RT-PCR detected ADRB-2 in
GCs of a large human follicle after excision by LMD
(Figure 2C).
NE in follicular fluid of preovulatory follicles of rhesus
monkey
The presence of NE in FF and thus in the monkey fol-
licular GC compartment, which lacks nerve fibers, was
confirmed using samples from preovulatory follicles ob-
tained from animals prior to receiving exogenous gonad-
otropins to induce the growth of multiple antral follicles
(0.37 + 0.05 ng/ml; mean + SEM; n = 7; ELISA). As re-
cently found in human FF [3], macaque FF NE levelsecal cells (TC) (A-C), interstitial cells and surface epithelium (D, E) in
The section shown in B was counterstained to visualize the nuclei of
p) mRNA in isolated monkey follicles by semi-nested RT-PCR small
) (G); co: control with RNA instead of cDNA.
Figure 2 ADRB-2 in human ovary. ADRB-2 in small (A) and large antral (B) human follicles. Control (B, bottom). Bars: 50 μm. (C) Detection of ADRB-2
(100 bp) in GCs of large human follicles. Sections before (top) and after excision (middle) by LMD and RT-PCR result (bottom). Control: no input cDNA.
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tion limit of 0.2 ng/ml in monkeys.
Growth of monkey follicles in 3D culture
Multilayered, secondary follicles grew in 3D culture
and developed an antrum (Figure 3A). At the end of
the approximately 1 month culture period, surviving
follicles (for criteria see definition in materials and
methods) expressed aromatase and FSHR mRNA. However,
only a fraction of those also co-expressed ADBR-2 mRNA
(Figure 3B). Neither ISO, nor NE treatment during culture
affected ADBR-2, aromatase or FSHR mRNAs.
When the sizes of the surviving follicles were analyzed,
those expressing ADRB-2 were significantly larger than
ADRB-2 negative follicles (Figure 4A). However, adren-
ergic stimulation of ADRB-2-negative and -positive folli-
cles, did not significantly affect follicular diameter at theFigure 3 Monkey secondary follicles grown in a 3D culture
system. Example of a monkey secondary follicle grown in a 3D culture
system: Size at the beginning (left) and at the end of the culture when
this follicle achieved the small antral stage (right; 35 days) (A). All 16
follicles that were examined upon termination of the culture express
aromatase and receptors for FSH (FSHR), but only a few (7) express
ADRB-2 (B).end of the experiment (Figure 4A), nor its increase dur-
ing in culture (data not shown; for both nonparametric
one-way ANOVA (Kruskal-Wallis test) followed by
Dunn’s post-test (alpha = 0.1)). Therefore, we pooled our
data into two groups based on RT-PCR analysis of
ADRB-2 in follicles at the end of culture: (1) ADRB-2-
positive (n = 16) and ADRB-2-negative (n = 67) follicles.
When analyzing changes of follicle size during culture,
we found that ADRB-2-positive follicles had a signifi-
cantly larger diameter, both at the beginning (d2) and
the end (d35) of the culture experiment (Figure 4B;
Mann–Whitney test, P < 0.0001 for both ages). There is
also a general correlation of diameter at d2 and d35
evident (Figure 4B; correlation analysis, Spearman r =
0.6712, P < 0.0001). ADRB-2-positive follicles show a sig-
nificantly larger increase in absolute follicular diameter
(median = 360 μm, 95% CI interval: 302–505; n = 16)
compared to their receptor negative counterparts (192
μm; 95% CI interval: 195–272; n = 67; data not shown;
Mann–Whitney test, P < 0.0001). In contrast, we ob-
served no difference in relative increase (data not shown;
Mann–Whitney test, P = 0.85) due to the already larger
diameters at the start of the experiments.
Discussion
Our studies on the human ovary and that on a clinically
relevant animal model, the rhesus monkey, gave identi-
cal results with regard to the expression pattern of
ADRB-2. Several distinct cell types of the human and
monkey ovary express ADRB-2 mRNA and protein, im-
plying that they are potential targets for the neurotrans-
mitter NE, which is derived primarily from ovarian
innervation and was readily found in FF of large antral
follicles. Based on this result and on the observed
ADRB-2 expression by follicular GCs, 3D cultures of
monkey preantral follicles were performed. Although the
addition of ISO or NE did not promote growth of
Figure 4 Dependency of follicle size and growth on ADRB-2 presence. Adrenergic stimulation does not affect follicular growth (A). Secondary
follicles isolated from macaque ovaries (n = 4 animals) were cultured in media containing FSH alone, or with norepinephrine (NE), isoproterenol (ISO).
Follicles were grouped depending upon their diameter (at day 35) and the absence or presence of ADRB-2. Note that ADRB-positive follicles were
significantly (P < 0.05) larger at d35 for all treatment groups. However, adrenergic treatment did not affect the diameters either ADRB-2-negative or
-positive follicles (nonparametric one-way ANOVA (Kruskal-Wallis test) followed by Dunns post-test (alpha = 0.1)). Lines represent medians for the
respective groups. (B) Follicle diameter and growth in culture depends on the presence of ADRB-2. Diameters of ADRB-2-positive (red; n = 16) and
ADRB-2-negative follicles (green; n = 67) at beginning (dstart) and end (dend) of culture. The lines show the linear correlation between diameters at the
beginning and end of culture.
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pression of ADRB-2 was associated with the largest folli-
cles at the time of isolation from the ovary and at the
end of culture. This suggests ADRB-2-mediated actions
in the development of follicles and that ADRB-2 expres-
sion may be a signature of fast growing follicles.
Both ADRB-2 protein and/or mRNA were localized to
several ovarian compartments. Ovarian surface epithe-
lium and interstitial cells, as well as the somatic cells of
the follicles, TCs and GCs, express this receptor. The
expression of ADRB-2 by the ovarian surface epithelium
has to our knowledge not yet been reported. TCs, GCs
and interstitial cells of several non-primate species are
known to express ADRB-2 [10,11,24,36-39].
To what extend follicles in human or monkey ovary
are innervated or associated with neuronal cellular ele-
ments, is not fully known ([1-7], yet GCs from primor-
dial and primary follicles and TCs of larger follicles
could in principle be in direct contact with nerve fibers
[40] and could therefore be immediate targets for
innervation-derived NE. Access of NE to GCs of larger
follicles always depends on diffusion. In larger follicles,
diffusion through the basal lamina and GC layers must
occur and we found evidence that this indeed occurs
during follicular growth. Thus, in FF of large monkey
follicles, NE accumulated and reached levels that are
much higher than serum levels. This is comparable to
the situation in the human ovary [3]. The reason and
mechanisms for accumulation in the FF remain un-
known, but may be related to the expression of NE- and
DA-transporters and storage-capacities of GCs withrespect to catecholamines [3,4,41] and to the ability of
oocytes to metabolize DA to NE [42]. These results es-
tablish that a ligand (NE in FF) and its receptor (ADRB-
2 in GCs) co-exist in the large antral monkey follicle.
Immunoreactivity for ADBR-2 of GCs of small primor-
dial and primary follicles was among the strongest
observed in the ovary. In previous rat studies, in which
postnatal ovaries were cultured, primordial and primary
follicles, responded to ISO and NE, which enhanced
growth of the follicles and the expression of FSHR [8].
The staining pattern suggests that a comparable role is
possible in the human and monkey and may depend on
the proximity to a source of NE, e.g. ovarian nerve fibers
releasing NE. A growth and differentiation-promoting
effect exerted by ADBR-2 stimulation is also supported
by data from studies in stem cells, other organs [13,14]
and tumor cells (see introduction e.g. [15]).
In our present study due to technical limitations, how-
ever, neither strongly immunopositive small follicles, nor
large antral follicles could not be examined and only
multilayered preantral monkey follicles, which showed
weaker and heterogeneous ADRB-2-staining of GCs,
could be cultured. It is possible that their patchy ADRB-
2 expression is related to the fact that in our culture
studies ISO and NE did not enhance follicular growth.
This point clearly requires additional studies. Further-
more, in contrast to the study in neonatal rat ovary [8],
monkey follicles in 3D culture depended on the presence
of FSH in the medium ([31] and pilot studies). Thus it is
possible that FSH, i.e. the prototype growth-promoting
hormone for GCs, may have masked the actions of NE.
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follicles at the time of their harvest revealed that all sur-
viving follicles examined, expressed FSHR and aromatase.
Yet, of these growing follicles only a fraction co-expressed
ADRB-2 at the mRNA level. Expression of ADRB-2 was
not correlated with the treatment in culture but was sig-
nificantly positively correlated with the size of the follicles
and their ability to grow in culture.
It is therefore possible that expression of ADRB-2 is of
advantage and that in vivo-growth of follicles, prior to
isolation, may have already been affected by intra-
ovarian NE. Thus, when the follicles expressing ADRB-2
were further analyzed and traced, it became clear that
they were already larger at the time of isolation than the
ones without ADRB-2. Unfortunately, their ADRB-2- as
well as FSHR-status at time of isolation could not be
verified. Yet, immunohistochemistry revealed that the
patchy expression of ADRB-2 by GCs in small, multi-
layered follicles is replaced by a more homogeneous
pattern in antral follicles. Given that NE, like in rat
stimulates expression of FSHR [8], this may link actions,
of NE with the observation that FSHR expression in-
creases in growing follicles [43]. Thus it is possible that
NE via ADRB-2 may stimulate both growth of small
follicle and induce FSHR, and thus contribute to fol-
licular development. Such an involvement in follicular
development of primates, possibly in the initial growth
as well as later in the large antral follicle, where NE is
present in significant levels in the FF, requires further
elucidation.
Finally, an intriguing possibility remains to be stud-
ied, namely whether ovarian ADRB-2 possess ligand-
independent activity. This was reported in other sys-
tems and was located to certain parts of the receptor
molecule [44]. If so, the mere presence of ADRB-2 may
indicate spontaneous activity, which could occur in the
absence of a ligand in many ovarian cells.
Conclusions
Based on ADRB-2 expression, many potential targets for
NE exist in the primate ovary, including monkey and
human GCs. While access of NE to these targets may
limit activation of ADRB-2, ligand-independent activity
of ADRB-2 may occur and ADRB-2 expression is associ-
ated with the best-growing follicles in culture. This topic
may be also of clinical interest. Thus drugs interfering
with ADRB-2 are commonly used to treat high blood
pressure and heart conditions. Based on the results of
our study they may have ovarian targets in women. They
may have actions in the human ovary and may possibly
impact human fertility [28].
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